NEW YORK (GenomeWeb) – Veractye's first quarter revenues increased 70 percent year over year, the molecular cytology firm announced after the close of the market on Thursday.

The South San Francisco, Calif.-based company said that for the three months ended March 31, revenues rose to $7.5 million from $4.4 million in the year-ago quarter as it received 14,373 fine need aspiration samples during the recently completed quarter, compared to 10,757 in the first quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.